Britain’s medicines regulator said four prescription-only Zantac medicines, including a syrup, an injection and tablets in 150 and 300 milligram doses, would be recalled.
Over-the-counter Zantac products are produced by a different company.
The decision is “precautionary” as health regulators in the U.S. and U.K. continue to review the safety of products with ranitidine, a drug that reduces stomach acid.
More articles on pharmacy:
Telemedicine startup to open first brick-and-mortar pharmacy
Top 10 pharmacy stories in September
Novant Health to open health clinics inside Walgreens
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
